Global Pharmaceuticals & Biotech Mid-Large Cap Stocks

Shanghai Medicilon

Market Cap: CN¥9.1b

A contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally.

Beijing SL Pharmaceutical

Market Cap: CN¥7.4b

A biopharmaceutical company, research, develops, produces, and markets genetic engineering and related drugs in the People’s Republic of China and internationally.

Mineralys Therapeutics

Market Cap: US$3.1b

A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.

ICON

Market Cap: US$15.0b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Philogen

Market Cap: €954.3m

A biotechnology company, develops drugs for oncology and chronic inflammatory diseases in Switzerland and the European Union.

Idorsia

Market Cap: CHF 930.4m

A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.

PTC Therapeutics

Market Cap: US$5.0b

A biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.

Mirum Pharmaceuticals

Market Cap: US$3.6b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

BGM Group

Market Cap: US$1.9b

Through its subsidiaries, operates as a pharmaceutical and chemical company in China.

InventisBio

Market Cap: CN¥18.0b

A clinical stage biotech company, engages in the discovery and development of therapeutics for cancer and metabolic diseases in China and the United States.

BioMarin Pharmaceutical

Market Cap: US$10.7b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

ImmunityBio

Market Cap: US$2.4b

A commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases.

GenFleet Therapeutics (Shanghai)

Market Cap: HK$14.1b

Operates as a biopharmaceutical company that focuses on developing novel treatment options in the fields of oncology that cover different lines of treatments of multiple solid tumors, as well as autoimmune and inflammatory diseases.

SanBio

Market Cap: JP¥240.2b

Develops, produces, and sells regenerative cell medicines for the central nervous system.

CStone Pharmaceuticals

Market Cap: HK$11.5b

A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally.

CanSino Biologics

Market Cap: HK$16.9b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

Piramal Pharma

Market Cap: ₹263.5b

Operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally.

InnoCare Pharma

Market Cap: HK$36.6b

A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.

Alphamab Oncology

Market Cap: HK$14.9b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biotherapeutics for cancer treatment in the People’s Republic of China.

Genscript Biotech

Market Cap: HK$37.5b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

Nanjing Leads Biolabs

Market Cap: HK$14.4b

A clinical-stage biotechnology company, engages in the research, development, and commercialisation of novel antibody drugs worldwide.

Keymed Biosciences

Market Cap: HK$21.9b

A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China and internationally.

LigaChem Biosciences

Market Cap: ₩5.5t

A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.

OliX Pharmaceuticals

Market Cap: ₩1.8t

A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.

Sierra Oncology

Market Cap: US$1.3b

Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.

Zai Lab

Market Cap: US$3.8b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Regencell Bioscience Holdings

Market Cap: US$8.0b

Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.

Apellis Pharmaceuticals

Market Cap: US$2.9b

A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.

Celcuity

Market Cap: US$2.1b

A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.

Protagonist Therapeutics

Market Cap: US$4.0b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

Alvotech

Market Cap: US$2.6b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

Twist Bioscience

Market Cap: US$1.9b

Manufactures and sells synthetic DNA-based products.

Biohaven

Market Cap: US$1.6b

Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide.

PolyPeptide Group

Market Cap: CHF 824.8m

Operates as a contract development and manufacturing company in Europe, the United States, and India.

Immunovant

Market Cap: US$2.9b

A clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases.

Crinetics Pharmaceuticals

Market Cap: US$3.9b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.